Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs HDFC Bank Limited Common Stock (HDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs HDFC Bank Limited Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while HDFC Bank Limited Common Stock trades at $22.27 (market cap $110.31B). The key difference: HDFC Bank Limited Common Stock is far larger — about 8.8× Halozyme Therapeutics Inc. Common Stock's market cap, and HDFC Bank Limited Common Stock pays a 1.86% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and HDFC Bank Limited Common Stock for 1 Days on average.
| HALO | HDB | |
|---|---|---|
Market Cap | $12.58B | $110.31B |
Volume | 2,179,278 | 13,548,204 |
Sector | Health | Financials |
52-Week High | $115.22 | $37.18 |
52-Week Low | $61.63 | $21.84 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $14.19T |
Dividend Yield | — | 1.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About HDFC Bank Limited Common Stock
HDFC Bank provides retail, wholesale, and treasury banking services in India. Its offerings include deposits, lending, payments, trade finance, and financial services for individuals and businesses.
Read more on HDB →
